BPC-157 + KPV + Glutathione
Two compounds with opposite delivery problems, both solved wrong.
KPV has the best oral delivery argument of any peptide sold today, and this stack injects it. Glutathione is poorly absorbed by mouth, which is why people inject it, and injected glutathione is the form with no efficacy evidence and documented safety concerns.
Gut problems that have not settled, with a toxin theory attached.
This is the two-compound gut stack with glutathione added. The pair underneath it splits the job cleanly, which few stacks manage: one compound aimed at rebuilding the lining, one at calming the inflammation sitting on top of it.
Glutathione gets added by people who connect their gut problems to toxin exposure or immune dysfunction rather than to injury, diet or an autoimmune diagnosis. It is the body's main built-in antioxidant, and it does real work inside cells.
Some of its popularity here also arrives sideways. Glutathione is widely taken on its own for skin brightness, and a lot of people already have a vial.
BPC-157 is the reason the underlying pair has a following at all. It was pulled out of human stomach fluid in the early 1990s, where it seemed to protect the tissue around it. Its first documented effects were all gastrointestinal. Stomach ulcers healing. The gut lining holding up better. Less inflammation in the intestines of rats. In animals given colitis chemically, it reduced visible damage to the colon, lowered inflammatory signalling and improved how the tissue looked under a microscope.[9]
That is the largest animal literature of any compound on this site, and the gut is where it started rather than an application somebody found for it later.
Four benefits, and how well each one holds up.
Glutathione has good evidence for the third row and none for the fourth, which is the one it gets added for. And the evidence it does have comes from swallowing it, not injecting it.
Three questions, answered before anything else.
Two compounds, opposite route problems.
Getting a peptide into the body is usually the hard part, and these two have opposite versions of the difficulty. The stack handles both the same way, and that is wrong for each.
KPV is three amino acids long, short enough for a transporter called PepT1 to carry it into cells. In a healthy colon PepT1 barely shows up. In chronic inflammatory disease and colitis it rises.[1]
So inflamed gut tissue pulls the compound in harder, at exactly the moment you would want it to. The mouse colitis work behind this delivered the peptide in drinking water.[2]
Injecting it skips the mechanism that makes it interesting for the gut.
Glutathione has to break into its three amino acids to cross the gut wall. Swallowing it does not reliably raise levels.[3] One study gave an oral dose to seven healthy volunteers and found no meaningful rise in blood glutathione for four and a half hours.[4]
That absorption problem is exactly why injecting became popular. But for the injected form, one review states plainly that there is no evidence proving it works.[4]
The route with the evidence gap is the one this stack uses.
Neither of these is a reason the stack cannot work. Both are reasons to know what you are choosing. If the target is the gut, KPV has a documented route that a syringe goes around. If the goal is raising glutathione, the evidence for doing it by injection is thinner than the evidence for doing it by mouth.
Good evidence for one thing, none for the thing it is added for.
Glutathione is added to this stack for detoxification. No human trial has tested a detox outcome at all. One evidence assessment grades that claim as insufficient, with no dedicated randomised trial identified beyond studies showing the compound raises the body's own antioxidant stores.[5]
What it does have is a real independent trial on the thing it is not being taken for here. A six-month trial in 54 adults at Penn State tested oral glutathione. Blood levels rose 17 to 30 percent. Cheek cell levels rose 260 percent. A measure of immune cell activity more than doubled at three months.[5]
That is moderate-strength evidence that taking glutathione raises your glutathione. It is not evidence that doing so clears toxins, settles a gut or changes anything you would notice.
The skin-lightening research is the largest body of work on the compound, and it is separate again. Its evidence is graded weak for oral use and contested for injection.[5] Two of the trials most often cited for oral glutathione used a brand made by the company funding them.[4]
Injected glutathione is the one with reported harms.
Oral glutathione holds GRAS status, the FDA category for ingredients generally recognised as safe in food, and topical and oral forms are both considered safe.[4][6]
The intravenous form is different. One review says it has not proven its safety or that it works. It also notes reported effects on kidney and thyroid function.[6] Some governments have banned injected glutathione for skin whitening because of the potential for misuse.[7]
Neither BPC-157 nor KPV has a registered clinical trial with systematic side effect collection, so there are no placebo-controlled rates to quote for either. Both are widely described as well tolerated, and that rests on an absence of reports rather than on anyone counting.
No study has given all three compounds together, or any two of them. Our own search turned up nothing. It was not a systematic review, so point us at a trial and we will update the page.
Three compounds, three positions.
KPV came off the FDA's restricted list in April 2026 and was recommended for the 503A Bulks List in July 2026, the register of ingredients compounding pharmacies may work with. That recommendation has not been finalised, and turning one into a rule runs eight to twenty-four months when it happens at all.[1]
BPC-157 went through the same July 2026 review. Neither compound has FDA approval for any use.
Glutathione is the outlier. As an oral supplement it is generally recognised as safe, and sold freely in the United States, the Philippines and Japan.[4] Injecting it is a different question, and the answer varies by country.
What people ask about this stack
Does glutathione detox anything?
No human trial has tested a detox outcome. One evidence assessment grades that claim insufficient, with no dedicated randomised trial found beyond studies showing glutathione raises the body's own antioxidant stores. Raising your glutathione is well supported. What that raise does for you is the part nobody has measured.
Is injected glutathione better than oral?
Injecting became popular because oral absorption is poor, and the injected form is the one with less evidence, not more. One review states there is no evidence proving intravenous glutathione works and that it has not proven its safety, with reported effects on kidney and thyroid function. Some governments have banned it for skin whitening. Meanwhile a six-month independent trial found oral glutathione did raise body stores.
Should KPV be taken by mouth instead?
For a gut target the argument points that way. KPV enters cells through a transporter that becomes more common in inflamed gut tissue, and the mouse colitis studies behind it delivered the peptide in drinking water. Injecting bypasses that. No human trial has tested either route, so this is a mechanism argument rather than a finding.
Is the third compound worth adding?
The two-compound version costs $44.44 and the three-compound version $74.39, so glutathione is about $30 of it. Its evidence is strong for raising antioxidant stores by mouth, weak for skin lightening, contested for injection and absent for detox. The gut rationale rests on the least supported of those.
Is glutathione safe to inject?
Less established than the oral form. Oral and topical glutathione are both considered safe and the oral version holds GRAS status, the FDA category for ingredients generally recognised as safe in food. One review states the intravenous form has not proven its safety or efficacy and notes reported effects on kidney and thyroid function. Some governments have banned injected glutathione for skin whitening.
Has anyone studied the combination?
No study we could find has given all three together, or any two of them, in people or animals. Each has its own separate literature. Compare against the other stacks.
What this page is built on
- 01KPV and PepT1: colonic expression minimal in health and rising in chronic inflammatory disease. KPV removed from Category 2 April 2026, recommended for the 503A Bulks List July 2026, not finalised.
- 02Dalmasso et al., PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 2008. PMID 18242607. Peptide delivered in drinking water in mouse colitis models.
- 03Systemic glutathione as a skin-whitening agent in adults. PMC7196133. Source for glutathione needing to break into three amino acid components before absorption across the intestinal tract.
- 04Glutathione as a skin whitening agent: facts, myths, evidence and controversies. Indian Journal of Dermatology, Venereology and Leprology. Source for the Witschi study in seven volunteers finding no significant plasma rise for up to 270 minutes, the absence of evidence for intravenous efficacy, the industry funding behind two supportive oral trials, and GRAS status.
- 05Independent evidence assessment grading glutathione claims. Richie 2015, six-month randomised trial in 54 adults at Penn State, NCT01044277: blood glutathione up 17 to 30 percent, buccal cells up 260 percent at 1,000 mg daily, natural killer cell activity more than doubled at three months. Detox claim graded insufficient.
- 06Glutathione for skin lightening review. Source for topical and oral forms being considered safe, the intravenous form not having proven safety or efficacy, and reported adverse effects on renal and thyroid function.
- 07Clinical review of glutathione absorption routes, noting that some governments have banned parenteral glutathione for skin whitening because of perceived misuse potential.
- 09BPC-157 isolated in the early 1990s as a protective factor in human gastric secretions, with TNBS colitis rat data reducing colon damage scores, lowering inflammatory cytokine levels and improving tissue appearance under a microscope.
- 08Peptide Decoding vendor pricing data, 16 September 2026. Lowest in-stock single-compound listings: BPC-157 $19.19, KPV $25.25, glutathione $29.95.